NASHVILLE, Tenn., November 17, 2025--i3 Verticals, Inc. (Nasdaq: IIIV) ("i3 Verticals" or the "Company") today reported its financial results for the fiscal fourth quarter and year ended September 30, ...

San Juan County residents are confronting a harsh reality: The possible loss of Affordable Care Act subsidies is exposing ...

ApproaCH was a randomized, double-blind, placebo-controlled trial evaluating TransCon CNP in 84 children with achondroplasia ages 2-11, randomized 2:1 to receive TransCon CNP at the 100 μg/kg/week ...